Skip to main content
Top
Gepubliceerd in: Quality of Life Research 3/2011

01-04-2011

Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controls

Auteurs: Lukas Jyuhn-Hsiarn Lee, Chih-Wen Chung, Yu-Yin Chang, Yung-Chie Lee, Chih-Hsin Yang, Saou-Hsing Liou, Pang-Hsiang Liu, Jung-Der Wang

Gepubliceerd in: Quality of Life Research | Uitgave 3/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

We explored covariates of the quality of life (QOL) in non-small-cell lung cancer (NSCLC) patients and made a comparison with healthy controls.

Methods

We assessed the QOL of 220 consecutive NSCLC patients at a university hospital. The QOL data were measured by the brief version of the World Health Organization’s Quality of Life and by utility using the standard gamble method. We selected demographically matched healthy controls from the 2001 National Health Interview Survey for comparison. Multiple linear regression models were constructed to explore significant factors of QOL after controlling for covariates.

Results

Patients with more advanced stages of NSCLC had poorer scores than did the healthy controls in the physical and psychological domains. Patients with disease duration of longer than 1 year tended to report higher physical and environment QOL than did those with NSCLC diagnosed for less than 1 year. Insight into one’s own illness was associated with a higher utility, better social support, and improved financial resources.

Conclusions

QOL was significantly associated with staging and duration of NSCLC. Disease insight appears to be a positive factor for operable NSCLC patients of the Taiwanese culture, which implies that clinicians should respect patient autonomy in diagnosis disclosure.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Boyle, P., Levin, B., International Agency for Research on Cancer, & World Health Organization. (2008). World cancer report 2008. Lyon, Geneva: International Agency for Research on Cancer; Distributed by WHO Press. Boyle, P., Levin, B., International Agency for Research on Cancer, & World Health Organization. (2008). World cancer report 2008. Lyon, Geneva: International Agency for Research on Cancer; Distributed by WHO Press.
2.
go back to reference Alberg, A. J., Ford, J. G., & Samet, J. M. (2007). Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 132(3 Suppl), 29S–55S.PubMedCrossRef Alberg, A. J., Ford, J. G., & Samet, J. M. (2007). Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 132(3 Suppl), 29S–55S.PubMedCrossRef
5.
go back to reference Camps, C., del Pozo, N., Blasco, A., Blasco, P., & Sirera, R. (2009). Importance of quality of life in patients with non-small-cell lung cancer. Clinical Lung Cancer, 10(2), 83–90.PubMedCrossRef Camps, C., del Pozo, N., Blasco, A., Blasco, P., & Sirera, R. (2009). Importance of quality of life in patients with non-small-cell lung cancer. Clinical Lung Cancer, 10(2), 83–90.PubMedCrossRef
6.
go back to reference Gridelli, C., Perrone, F., Nelli, F., Ramponi, S., & De Marinis, F. (2001). Quality of life in lung cancer patients. Annals of Oncology, 12(Suppl 3), S21–S25.PubMedCrossRef Gridelli, C., Perrone, F., Nelli, F., Ramponi, S., & De Marinis, F. (2001). Quality of life in lung cancer patients. Annals of Oncology, 12(Suppl 3), S21–S25.PubMedCrossRef
7.
go back to reference Movsas, B. (2003). Quality of life in oncology trials: A clinical guide. Seminars in Radiation Oncology, 13(3), 235–247.PubMedCrossRef Movsas, B. (2003). Quality of life in oncology trials: A clinical guide. Seminars in Radiation Oncology, 13(3), 235–247.PubMedCrossRef
9.
go back to reference Sloan, J. A., Frost, M. H., Berzon, R., Dueck, A., Guyatt, G., Moinpour, C., et al. (2006). The clinical significance of quality of life assessments in oncology: A summary for clinicians. Supportive Care in Cancer, 14(10), 988–998.PubMedCrossRef Sloan, J. A., Frost, M. H., Berzon, R., Dueck, A., Guyatt, G., Moinpour, C., et al. (2006). The clinical significance of quality of life assessments in oncology: A summary for clinicians. Supportive Care in Cancer, 14(10), 988–998.PubMedCrossRef
10.
go back to reference Sugimura, H., & Yang, P. (2006). Long-term survivorship in lung cancer: A review. Chest, 129(4), 1088–1097.PubMedCrossRef Sugimura, H., & Yang, P. (2006). Long-term survivorship in lung cancer: A review. Chest, 129(4), 1088–1097.PubMedCrossRef
11.
go back to reference Skevington, S. M., Lotfy, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13(2), 299–310.PubMedCrossRef Skevington, S. M., Lotfy, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13(2), 299–310.PubMedCrossRef
12.
go back to reference Heshmat, S. (2001). An overview of managerial economics in the health care system. Albany, NY: Delmar Series in Health Services Administration. Heshmat, S. (2001). An overview of managerial economics in the health care system. Albany, NY: Delmar Series in Health Services Administration.
13.
go back to reference Neumann, P. J., Goldie, S. J., & Weinstein, M. C. (2000). Preference-based measures in economic evaluation in health care. Annual Review of Public Health, 21, 587–611.PubMedCrossRef Neumann, P. J., Goldie, S. J., & Weinstein, M. C. (2000). Preference-based measures in economic evaluation in health care. Annual Review of Public Health, 21, 587–611.PubMedCrossRef
14.
go back to reference Stein, K., Dyer, M., Milne, R., Round, A., Ratcliffe, J., & Brazier, J. (2009). The precision of health state valuation by members of the general public using the standard gamble. Quality of Life Research, 18(4), 509–518.PubMedCrossRef Stein, K., Dyer, M., Milne, R., Round, A., Ratcliffe, J., & Brazier, J. (2009). The precision of health state valuation by members of the general public using the standard gamble. Quality of Life Research, 18(4), 509–518.PubMedCrossRef
15.
go back to reference Revicki, D. A., & Kaplan, R. M. (1993). Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Quality of Life Research, 2(6), 477–487.PubMedCrossRef Revicki, D. A., & Kaplan, R. M. (1993). Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Quality of Life Research, 2(6), 477–487.PubMedCrossRef
16.
go back to reference Svobodnik, A., Yang, P., Novotny, P. J., Bass, E., Garces, Y. I., Jett, J. R., et al. (2004). Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. Mayo Clinic Proceedings, 79(8), 1024–1030.PubMedCrossRef Svobodnik, A., Yang, P., Novotny, P. J., Bass, E., Garces, Y. I., Jett, J. R., et al. (2004). Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. Mayo Clinic Proceedings, 79(8), 1024–1030.PubMedCrossRef
17.
go back to reference Mountain, C. F. (1997). Revisions in the international system for staging lung cancer. Chest, 111(6), 1710–1717.PubMedCrossRef Mountain, C. F. (1997). Revisions in the international system for staging lung cancer. Chest, 111(6), 1710–1717.PubMedCrossRef
18.
go back to reference Hung, Y. T. (2002). Sampling design of the National Health Interview Survey. NHIS Brief Communication No. 2. Hung, Y. T. (2002). Sampling design of the National Health Interview Survey. NHIS Brief Communication No. 2.
19.
go back to reference Lin, S. H. (2002). Field collection and completeness of data in the National Health Interview Survey. NHIS Brief Communication No. 4. Lin, S. H. (2002). Field collection and completeness of data in the National Health Interview Survey. NHIS Brief Communication No. 4.
20.
go back to reference The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558.CrossRef The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558.CrossRef
21.
go back to reference Yao, G., Chung, C. W., Yu, C. F., & Wang, J. D. (2002). Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. Journal of the Formosan Medical Association, 101(5), 342–351.PubMed Yao, G., Chung, C. W., Yu, C. F., & Wang, J. D. (2002). Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. Journal of the Formosan Medical Association, 101(5), 342–351.PubMed
22.
go back to reference The WHOQOL-BREF Group. (2006). The user’s manual of the development of the WHOQOL-BREF Taiwan Version, revised 2nd Ed. Taipei, Taiwan. The WHOQOL-BREF Group. (2006). The user’s manual of the development of the WHOQOL-BREF Taiwan Version, revised 2nd Ed. Taipei, Taiwan.
23.
go back to reference Bala, M. V., Wood, L. L., Zarkin, G. A., Norton, E. C., Gafni, A., & O’Brien, B. J. (1999). Are health states “timeless”? The case of the standard gamble method. Journal of Clinical Epidemiology, 52(11), 1047–1053.PubMedCrossRef Bala, M. V., Wood, L. L., Zarkin, G. A., Norton, E. C., Gafni, A., & O’Brien, B. J. (1999). Are health states “timeless”? The case of the standard gamble method. Journal of Clinical Epidemiology, 52(11), 1047–1053.PubMedCrossRef
24.
go back to reference Gold, M. R., Patrick, D. L., Torrance, G. W., Fryback, D. G., Hadorn, D. C., Kamlet, M. S., et al. (1996). Identifying and valuing outcomes. In M. R. Gold, J. E. Siegel, L. B. Russel, & M. C. Weinstein (Eds.), Cost-effectiveness in health and medicine (pp. 113–115). New York: Oxford University Press. Gold, M. R., Patrick, D. L., Torrance, G. W., Fryback, D. G., Hadorn, D. C., Kamlet, M. S., et al. (1996). Identifying and valuing outcomes. In M. R. Gold, J. E. Siegel, L. B. Russel, & M. C. Weinstein (Eds.), Cost-effectiveness in health and medicine (pp. 113–115). New York: Oxford University Press.
25.
go back to reference Wyrwich, K. W., Bullinger, M., Aaronson, N., Hays, R. D., Patrick, D. L., & Symonds, T. (2005). Estimating clinically significant differences in quality of life outcomes. Quality of Life Research, 14(2), 285–295.PubMedCrossRef Wyrwich, K. W., Bullinger, M., Aaronson, N., Hays, R. D., Patrick, D. L., & Symonds, T. (2005). Estimating clinically significant differences in quality of life outcomes. Quality of Life Research, 14(2), 285–295.PubMedCrossRef
26.
go back to reference Pfister, D. G., Johnson, D. H., Azzoli, C. G., Sause, W., Smith, T. J., Baker, S., Jr., et al. (2004). American Society of Clinical Oncology treatment of unrespectable non-small-cell lung cancer guideline: Update 2003. Journal of Clinical Oncology, 22(2), 330–353.PubMedCrossRef Pfister, D. G., Johnson, D. H., Azzoli, C. G., Sause, W., Smith, T. J., Baker, S., Jr., et al. (2004). American Society of Clinical Oncology treatment of unrespectable non-small-cell lung cancer guideline: Update 2003. Journal of Clinical Oncology, 22(2), 330–353.PubMedCrossRef
27.
go back to reference Pisters, K. M., Evans, W. K., Azzoli, C. G., Kris, M. G., Smith, C. A., Desch, C. E., et al. (2007). Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. Journal of Clinical Oncology, 25(34), 5506–5518.PubMedCrossRef Pisters, K. M., Evans, W. K., Azzoli, C. G., Kris, M. G., Smith, C. A., Desch, C. E., et al. (2007). Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. Journal of Clinical Oncology, 25(34), 5506–5518.PubMedCrossRef
28.
go back to reference Freund, R. J., Littell, R. C., & Spector, P. C. (1986). SAS system for linear models. Cary, NC: SAS Institute. Freund, R. J., Littell, R. C., & Spector, P. C. (1986). SAS system for linear models. Cary, NC: SAS Institute.
29.
go back to reference Hwang, J. S., Tsauo, J. Y., & Wang, J. D. (1996). Estimation of expected quality adjusted survival by cross-sectional survey. Statistics in Medicine, 15(1), 93–102.PubMedCrossRef Hwang, J. S., Tsauo, J. Y., & Wang, J. D. (1996). Estimation of expected quality adjusted survival by cross-sectional survey. Statistics in Medicine, 15(1), 93–102.PubMedCrossRef
30.
go back to reference Watson, G. S. (1964). Smooth regression analysis. Sankhyā: The Indian Journal of Statistics, Series A, 26(4), 359–372. Watson, G. S. (1964). Smooth regression analysis. Sankhyā: The Indian Journal of Statistics, Series A, 26(4), 359–372.
31.
go back to reference Huang, I. C., Frangakis, C., & Wu, A. W. (2006). The relationship of excess body weight and health-related quality of life: Evidence from a population study in Taiwan. International Journal of Obesity, 30(8), 1250–1259.PubMedCrossRef Huang, I. C., Frangakis, C., & Wu, A. W. (2006). The relationship of excess body weight and health-related quality of life: Evidence from a population study in Taiwan. International Journal of Obesity, 30(8), 1250–1259.PubMedCrossRef
32.
go back to reference Lee, L. J., Chen, C. H., Yao, G., Chung, C. W., Sheu, J. C., Lee, P. H., et al. (2007). Quality of life in patients with hepatocellular carcinoma received surgical resection. Journal of Surgical Oncology, 95(1), 34–39.PubMedCrossRef Lee, L. J., Chen, C. H., Yao, G., Chung, C. W., Sheu, J. C., Lee, P. H., et al. (2007). Quality of life in patients with hepatocellular carcinoma received surgical resection. Journal of Surgical Oncology, 95(1), 34–39.PubMedCrossRef
33.
go back to reference Lheureux, M., Raherison, C., Vernejoux, J. M., Nguyen, L., Nocent, C., Tunon De Lara, M., et al. (2004). Quality of life in lung cancer: Does disclosure of the diagnosis have an impact? Lung Cancer, 43(2), 175–182.PubMedCrossRef Lheureux, M., Raherison, C., Vernejoux, J. M., Nguyen, L., Nocent, C., Tunon De Lara, M., et al. (2004). Quality of life in lung cancer: Does disclosure of the diagnosis have an impact? Lung Cancer, 43(2), 175–182.PubMedCrossRef
34.
go back to reference Fan, R., & Li, B. (2004). Truth telling in medicine: The Confucian view. The Journal of Medicine and Philosophy, 29(2), 179–193.PubMedCrossRef Fan, R., & Li, B. (2004). Truth telling in medicine: The Confucian view. The Journal of Medicine and Philosophy, 29(2), 179–193.PubMedCrossRef
35.
go back to reference Lin, C. C. (1999). Disclosure of the cancer diagnosis as it relates to the quality of pain management among patients with cancer pain in Taiwan. Journal of Pain and Symptom Management, 18(5), 331–337.PubMedCrossRef Lin, C. C. (1999). Disclosure of the cancer diagnosis as it relates to the quality of pain management among patients with cancer pain in Taiwan. Journal of Pain and Symptom Management, 18(5), 331–337.PubMedCrossRef
Metagegevens
Titel
Comparison of the quality of life between patients with non-small-cell lung cancer and healthy controls
Auteurs
Lukas Jyuhn-Hsiarn Lee
Chih-Wen Chung
Yu-Yin Chang
Yung-Chie Lee
Chih-Hsin Yang
Saou-Hsing Liou
Pang-Hsiang Liu
Jung-Der Wang
Publicatiedatum
01-04-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 3/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9761-y

Andere artikelen Uitgave 3/2011

Quality of Life Research 3/2011 Naar de uitgave